Saygideger-Kont, Y. Et Al. 2016. Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells. NEOPLASIA , vol.18, no.2 , 111-120.

Saygideger-Kont, Y., Minas, T. Z., Jones, H., Hour, S., Celik, H., Temel, I., ... Han, J.(2016). Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells. NEOPLASIA , vol.18, no.2, 111-120.

Saygideger-Kont, YASEMİN Et Al. "Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells," NEOPLASIA , vol.18, no.2, 111-120, 2016

Saygideger-Kont, YASEMİN Et Al. "Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells." NEOPLASIA , vol.18, no.2, pp.111-120, 2016

Saygideger-Kont, Y. Et Al. (2016) . "Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells." NEOPLASIA , vol.18, no.2, pp.111-120.

@article{article, author={YASEMİN SAYGIDEĞER Et Al. }, title={Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells}, journal={NEOPLASIA}, year=2016, pages={111-120} }